GB2077590A - Highly attenuated varicella virus vaccine and production thereof - Google Patents

Highly attenuated varicella virus vaccine and production thereof

Info

Publication number
GB2077590A
GB2077590A GB8123471A GB8123471A GB2077590A GB 2077590 A GB2077590 A GB 2077590A GB 8123471 A GB8123471 A GB 8123471A GB 8123471 A GB8123471 A GB 8123471A GB 2077590 A GB2077590 A GB 2077590A
Authority
GB
United Kingdom
Prior art keywords
varicella virus
virus vaccine
production
highly attenuated
attenuated varicella
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
GB8123471A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
The Wistar Institute
Original Assignee
The Wistar Institute
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by The Wistar Institute filed Critical The Wistar Institute
Publication of GB2077590A publication Critical patent/GB2077590A/en
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/245—Herpetoviridae, e.g. herpes simplex virus
    • A61K39/25—Varicella-zoster virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5254—Virus avirulent or attenuated
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/16011—Herpesviridae
    • C12N2710/16711—Varicellovirus, e.g. human herpesvirus 3, Varicella Zoster, pseudorabies
    • C12N2710/16734—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/16011—Herpesviridae
    • C12N2710/16711—Varicellovirus, e.g. human herpesvirus 3, Varicella Zoster, pseudorabies
    • C12N2710/16761—Methods of inactivation or attenuation
    • C12N2710/16764—Methods of inactivation or attenuation by serial passage

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Virology (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Public Health (AREA)
  • Zoology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Mycology (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
GB8123471A 1980-01-25 1981-01-21 Highly attenuated varicella virus vaccine and production thereof Withdrawn GB2077590A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US11543780A 1980-01-25 1980-01-25

Publications (1)

Publication Number Publication Date
GB2077590A true GB2077590A (en) 1981-12-23

Family

ID=22361396

Family Applications (1)

Application Number Title Priority Date Filing Date
GB8123471A Withdrawn GB2077590A (en) 1980-01-25 1981-01-21 Highly attenuated varicella virus vaccine and production thereof

Country Status (5)

Country Link
EP (1) EP0043847A4 (cg-RX-API-DMAC10.html)
JP (1) JPS57500149A (cg-RX-API-DMAC10.html)
GB (1) GB2077590A (cg-RX-API-DMAC10.html)
IT (1) IT8147637A0 (cg-RX-API-DMAC10.html)
WO (1) WO1981002107A1 (cg-RX-API-DMAC10.html)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6181782A (ja) * 1984-09-28 1986-04-25 Teijin Ltd 抗ウイルス・ヒト抗体を産生するマウス−ヒトハイブリド−マ及びその製造法並びにその使用方法

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL7103524A (cg-RX-API-DMAC10.html) * 1970-04-28 1971-11-01
DE2201877A1 (de) * 1972-01-15 1973-07-19 Steyr Daimler Puch Ag Entlueftungsvorrichtungfuer das kurbelgehaeuse ventilgesteuerter brennkraftmaschinen
JPS5119018B2 (cg-RX-API-DMAC10.html) * 1972-06-10 1976-06-14
JPS5341202B2 (cg-RX-API-DMAC10.html) * 1974-03-12 1978-11-01
US4000256A (en) * 1975-04-30 1976-12-28 Merck & Co., Inc. Varicella vaccine and process for its preparation
GB1481650A (en) * 1975-05-06 1977-08-03 Merck & Co Inc Chemical processes and products
BE828941A (fr) * 1975-05-12 1975-11-12 Vaccin et procede pour le preparer
FR2310772A1 (fr) * 1975-05-16 1976-12-10 Merck & Co Inc Vaccin contre la varicelle et procede pour sa preparation
CH624430A5 (en) * 1975-05-16 1981-07-31 Merck & Co Inc Process for the production of a chicken pox virus preparation
NL7506620A (en) * 1975-06-04 1976-12-07 Merck & Co Inc Cell-free chickenpox virus prodn - for vaccines, by passing on human or monkey cells until attenuated then recovering the virus in presence of a stabiliser
US4008317A (en) * 1975-12-29 1977-02-15 Recherche Et Industrie Therapeutiques (R.I.T.) Varicella-zoster virus vaccine and preparation thereof

Also Published As

Publication number Publication date
IT8147637A0 (it) 1981-01-26
WO1981002107A1 (en) 1981-08-06
EP0043847A1 (en) 1982-01-20
JPS57500149A (cg-RX-API-DMAC10.html) 1982-01-28
EP0043847A4 (en) 1982-07-06

Similar Documents

Publication Publication Date Title
SE7504221L (sv) Cellvirusvaccin och forfarande for framstellning av vaccinet.
EP0149040A3 (en) Modified live pseudorabies viruses, vaccines for pseudorabies disease containing same, methods for production of same and methods for use of same
ES2176232T3 (es) Vacuna adecuada para ser utilizada en la prevencion y tratamiento de la infeccion por helicobacter.
ZA948643B (en) Live in ovo vaccine
JPS557287A (en) Aryloxypropanol amine
GR3022755T3 (en) Chicken anaemia agent vaccine
NZ183907A (en) Attenuated live equine herpes i (equine rhinopneumonitis) virus and vaccine
ES2058237T3 (es) Metodo para la preparacion de una vacuna para combatir la infeccion mycoplasmica en aves de corral.
DE19875021I2 (de) Reinigungsverfahren der proteischen Antigene von Bordetella-Bakterien zur Gewinnung eines azellularen Vakzins.
NZ181498A (en) A live rabies virus and a vaccine there of
ATE360061T1 (de) Replikationsmangelhafte mutanten von herpesvirus
ES2002100A6 (es) Un procedimiento para preparar una vacuna viva contra la bronquitis infecciosa de aves de corral.
FR2385401A1 (fr) Vaccin a virus respiratoire syncytial
HUP9700975A2 (hu) Élő, legyengített, Pasteurellaceae családba tartozó, RTX-termelő baktériumok
CA962593A (en) Highly attenuated newcastle disease virus vaccine and production thereof
DK52783A (da) Vaccine indeholdende en ozon-inaktiveret mikroorganisme og fremgangsmaade til fremstilling af en saadan vaccine
ZA796944B (en) Vaccines against diseases,caused by reovirus,and process for the preparation of those vaccines
IE853109L (en) Vaccines against avian infectious bronchitis
DE2965191D1 (en) Herpes virus vaccine and its preparation
DE3279264D1 (en) Method of immunizing pigs against aujeszky's disease
Gorshunova et al. Persistence of the vaccinia virus and interferon production in the organs of vaccinated white mice
CHEN et al. The dynamic observation of the levels of IL-4 and IFN-? in the BALB/C mice infected with DV2 NGC strain
NZ243251A (en) Vaccine against marek's disease virus in poultry
AU454379B2 (en) Highly attenuated newcastle disease virus vaccine and production thereof
EP0043847A4 (en) HIGHLY ATTENUED CHICKENPOX VIRUS VACCINE AND PRODUCTION THEREOF.

Legal Events

Date Code Title Description
WAP Application withdrawn, taken to be withdrawn or refused ** after publication under section 16(1)